HUP0401985A3 - Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides - Google Patents

Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Info

Publication number
HUP0401985A3
HUP0401985A3 HU0401985A HUP0401985A HUP0401985A3 HU P0401985 A3 HUP0401985 A3 HU P0401985A3 HU 0401985 A HU0401985 A HU 0401985A HU P0401985 A HUP0401985 A HU P0401985A HU P0401985 A3 HUP0401985 A3 HU P0401985A3
Authority
HU
Hungary
Prior art keywords
polypeptides
factor
pharmaceutical composition
factor vii
vii polypeptides
Prior art date
Application number
HU0401985A
Other languages
Hungarian (hu)
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of HUP0401985A2 publication Critical patent/HUP0401985A2/en
Publication of HUP0401985A3 publication Critical patent/HUP0401985A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0401985A 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides HUP0401985A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101660 2001-11-09
PCT/DK2002/000736 WO2003039584A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Publications (2)

Publication Number Publication Date
HUP0401985A2 HUP0401985A2 (en) 2004-12-28
HUP0401985A3 true HUP0401985A3 (en) 2009-03-30

Family

ID=8160820

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401985A HUP0401985A3 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Country Status (16)

Country Link
EP (1) EP1446149A1 (en)
JP (1) JP2005511599A (en)
KR (1) KR20050043734A (en)
CN (1) CN1596125A (en)
AU (1) AU2002340779B2 (en)
BR (1) BR0213953A (en)
CA (1) CA2464615A1 (en)
CZ (1) CZ2004543A3 (en)
HU (1) HUP0401985A3 (en)
IL (1) IL161544A0 (en)
MX (1) MXPA04004304A (en)
NO (1) NO20042380L (en)
PL (1) PL370634A1 (en)
RU (1) RU2004117534A (en)
WO (1) WO2003039584A1 (en)
ZA (1) ZA200403271B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100411684C (en) 1999-07-14 2008-08-20 诺沃挪第克健康护理股份公司 Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
ES2381110T3 (en) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Coagulation Factor VII Polypeptides
WO2005074974A1 (en) * 2004-02-05 2005-08-18 Novo Nordisk Health Care Ag Use of factor viia for treating late complications of trauma
FR2894831B1 (en) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement THROMBIN FREE BIOLOGICAL GLUE AND USE THEREOF AS MEDICAMENT.
WO2007104317A1 (en) * 2006-03-16 2007-09-20 Drugrecure Aps Methods for local treatment with factor vii
CN105848668A (en) * 2013-11-04 2016-08-10 加利福尼亚大学董事会 Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0756638B1 (en) * 1994-04-22 2001-04-04 Stichting Sanquin Bloedvoorziening Means for treating disorders in the blood coagulation cascade
WO1998058661A1 (en) * 1997-06-23 1998-12-30 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
WO1999058699A2 (en) * 1998-05-14 1999-11-18 Battelle Memorial Institute Transgenic plant-derived human blood coagulation factors

Also Published As

Publication number Publication date
WO2003039584A1 (en) 2003-05-15
IL161544A0 (en) 2004-09-27
HUP0401985A2 (en) 2004-12-28
JP2005511599A (en) 2005-04-28
MXPA04004304A (en) 2004-08-11
ZA200403271B (en) 2004-11-08
CA2464615A1 (en) 2003-05-15
KR20050043734A (en) 2005-05-11
AU2002340779B2 (en) 2007-08-02
EP1446149A1 (en) 2004-08-18
RU2004117534A (en) 2005-05-10
PL370634A1 (en) 2005-05-30
NO20042380L (en) 2004-06-08
CN1596125A (en) 2005-03-16
CZ2004543A3 (en) 2004-08-18
BR0213953A (en) 2004-08-31

Similar Documents

Publication Publication Date Title
HUS1400025I1 (en) Phenethanolamine derivatives and pharmaceutical composition containing them
HUP0500989A2 (en) Animicrobial polypeptides and their uses
IL159015A0 (en) Polypeptides, their preparation and use
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
GB0108470D0 (en) Pharmaceutical compositions and their use
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
HUP0400976A3 (en) Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides
SI1462455T1 (en) Ser-Ser-Ser-Arg peptide and medicinal uses thereof
IL158397A0 (en) Polypeptides, their preparation and their use
IL159872A0 (en) Gmg-2 polypeptides and their use
EP1414848A4 (en) Replikin peptides and uses thereof
EP1419175A4 (en) Replikin peptides and uses thereof
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
EP1379228A4 (en) (z)-styrylbenzylsulfones and pharmaceutical uses thereof
HUP0401985A3 (en) Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
IL131266A0 (en) Peptides and pharmaceutical compositions comprising same
IL156711A0 (en) Peptide derivatives and pharmaceutical compositions containing the same
IL153176A (en) Phenylpiperazines and pharmaceutical compositions comprising them
EP1241257A4 (en) Novel tachykinin-like polypeptides and use thereof
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
HUP0401959A3 (en) Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
IL135442A0 (en) Peptides and pharmaceutical compositions comprising them
AU2002340777A1 (en) Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees